sameAs
Solution structure of human growth arrest and DNA damage 45alpha (Gadd45alpha) and its interactions with proliferating cell nuclear antigen (PCNA) and Aurora A kinaseEfficient targeting of a SCID gene by an engineered single-chain homing endonucleaseCrystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domainMolecular Basis of Histone H3K4me3 Recognition by ING4The NMR structure and dynamics of the two-domain tick carboxypeptidase inhibitor reveal flexibility in its free form and stiffness upon binding to human carboxypeptidase BThe NMR structures of the major intermediates of the two-domain tick carboxypeptidase inhibitor reveal symmetry in its folding and unfolding pathwaysCrystal structure of I-DmoI in complex with its target DNA provides new insights into meganuclease engineeringMolecular basis of engineered meganuclease targeting of the endogenous human RAG1 locusCrystal Structure of Inhibitor of Growth 4 (ING4) Dimerization Domain Reveals Functional Organization of ING Family of Chromatin-binding ProteinsStructure of p15(PAF)-PCNA complex and implications for clamp sliding during DNA replication and repairEngineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targetsReduced stability and increased dynamics in the human proliferating cell nuclear antigen (PCNA) relative to the yeast homologProliferating cell nuclear antigen (PCNA) interactions in solution studied by NMRIntramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domainsStructural basis of human PCNA sliding on DNA.Folding and aggregation kinetics of a beta-hairpin.In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequencesCrystallization and preliminary X-ray diffraction analysis of the dimerization domain of the tumour suppressor ING4.The heterotrimeric laminin coiled-coil domain exerts anti-adhesive effects and induces a pro-invasive phenotypeXTACC3-XMAP215 association reveals an asymmetric interaction promoting microtubule elongation.p15PAF is an intrinsically disordered protein with nonrandom structural preferences at sites of interaction with other proteins.Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.Rapid identification of fluorochrome modification sites in proteins by LC ESI-Q-TOF mass spectrometryTRAIP is a PCNA-binding ubiquitin ligase that protects genome stability after replication stressThe C-terminal RNA binding motif of HuR is a multi-functional domain leading to HuR oligomerization and binding to U-rich RNA targets.The metastasis suppressor KISS1 is an intrinsically disordered protein slightly more extended than a random coil.Crystal Structure of the Homing Endonuclease I-CvuI Provides a New Template for Genome Modification.Crystallization and preliminary X-ray diffraction analysis on the homing endonuclease I-Dmo-I in complex with its target DNA.Evolution of SUMO Function and Chain Formation in Insects.On the relevance of defining protein structures in cancer research.Crystallization and preliminary X-ray diffraction analysis of the homing endonuclease I-CvuI from Chlorella vulgaris in complex with its target DNA.Homing endonucleases: from basics to therapeutic applications.Transient DNA / RNA-protein interactions.Proliferating cell nuclear antigen structure and interactions: too many partners for one dancer?Disentangling polydispersity in the PCNA-p15PAF complex, a disordered, transient and multivalent macromolecular assembly.Design, synthesis, and functional evaluation of leukocyte function associated antigen-1 antagonists in early and late stages of cancer development.Structure of the I-SceI nuclease complexed with its dsDNA target and three catalytic metal ions.The dimeric structure and the bivalent recognition of H3K4me3 by the tumor suppressor ING4 suggests a mechanism for enhanced targeting of the HBO1 complex to chromatin.Expression, purification and crystallization of human CD5 domain III, a nano-scale crystallization example.Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events.
P50
Q24609808-70EF6E11-6103-4201-A61A-246AD0452AE8Q24654113-000655C7-9E65-4EE2-8152-CE9BCC3A0B06Q27643898-400119C4-09B2-4B41-81C9-33D0D5309779Q27650200-C373C5C9-DFC1-462C-9E3D-4BFF721CF2F8Q27650854-201542FA-82BA-4ABC-AE31-95CDC128EDEDQ27651262-193515EB-C3A9-472B-838B-42F37A7149E4Q27652711-ECAD4DAF-35E1-4F67-B514-562113E13720Q27664531-4B0C375D-8A70-409B-9380-08FCDE3FBAD5Q27677284-CFB92E34-D1BC-4C40-8ECF-05A652C004A1Q27698433-4A2985FD-5D7C-482E-9242-76CFD773B00AQ28283796-27C47692-6303-45D5-B9E8-CF51101BFAD1Q28477198-4C6F0B56-FAB2-4169-9F37-93DCA9ECF30EQ28484905-884FCF29-1C21-49DF-BD93-608B668F8694Q28597266-154E8B1C-A053-47C9-8B33-4874393F26EAQ30834894-FE594DE6-5312-4FAA-B105-BBE934B94104Q33245707-8775EB64-32C1-4F3F-AB13-57530ED9188DQ33436213-6C5992C2-99CE-4656-ACAA-04B393ED2FF9Q33830237-5909C992-A54A-4D54-B164-7DCFC0EA1802Q34314165-3FD979D5-8327-4BF0-8DB0-20C751257A0DQ34357171-22066070-A4F5-4AA0-B856-DC8DB0B15FBAQ34406035-F078E2B0-D169-4CD0-B900-D754584524A6Q35001301-E913737B-9F0A-4A1C-93CE-8ED695FEF9A5Q35118708-B9668AD6-934F-4B76-B957-98BB7647D156Q35880011-14666649-F7B4-49FF-8430-44849B0F9621Q36191766-B68C96FB-0037-4338-985D-BA5C6DD909B8Q36283040-47E51A05-4A77-4C13-A32F-D2A03A8CD7A0Q36323430-3ADB9348-E9FC-41A1-9E48-FEABB4070329Q36591764-00FB4310-427E-4FC7-9A05-2AA006654592Q36899962-1A682E58-51BF-4EAB-A446-2AA605450D60Q37138257-BFF1361C-5266-4685-A818-757404A4C5CEQ37606361-0217DE3B-A1C8-43C5-A55C-675CD3E63BCEQ37633432-63D63563-BAD0-417D-8D58-D5BE0E78D784Q37853621-D0D53F01-DDA2-42A4-89B3-9D82F993EF41Q38116107-A2FA3601-84E8-4D16-87C2-48051CA66A91Q38970740-C7217502-3859-4EFD-BCE7-9D4FBDB567A3Q39206764-E92BAF71-6A74-4BF1-B810-D7B0BB86A8A2Q39682169-B4803B3F-8D26-4E88-ABA4-0CCFDE76F9F4Q39755414-B3A62AFF-393B-4A6C-9D8E-ACDD85138DD7Q40163360-F74022EB-4250-449F-B3A4-ADC5052433FFQ40316534-6E4F4591-652C-42B0-AD31-5C242EB1F7F5
P50
description
Spaans bioloog
@nl
Spanish medical researcher
@en
ahli biologi
@id
biologiste espagnol
@fr
biologo espainiarra
@eu
biologo spagnolo
@it
biòleg espanyol
@ca
biólogo espanhol
@pt
biólogo español
@es
biólogo español
@gl
name
Francisco J. Blanco
@ace
Francisco J. Blanco
@ast
Francisco J. Blanco
@ca
Francisco J. Blanco
@en
Francisco J. Blanco
@es
Francisco J. Blanco
@fr
Francisco J. Blanco
@ga
Francisco J. Blanco
@id
Francisco J. Blanco
@nl
Francisco J. Blanco
@sl
type
label
Francisco J. Blanco
@ace
Francisco J. Blanco
@ast
Francisco J. Blanco
@ca
Francisco J. Blanco
@en
Francisco J. Blanco
@es
Francisco J. Blanco
@fr
Francisco J. Blanco
@ga
Francisco J. Blanco
@id
Francisco J. Blanco
@nl
Francisco J. Blanco
@sl
altLabel
Francisco J Blanco
@ast
Francisco J Blanco
@en
Francisco J Blanco
@es
Francisco J Blanco
@sl
Paco Blanco
@en
prefLabel
Francisco J. Blanco
@ace
Francisco J. Blanco
@ast
Francisco J. Blanco
@ca
Francisco J. Blanco
@en
Francisco J. Blanco
@es
Francisco J. Blanco
@fr
Francisco J. Blanco
@ga
Francisco J. Blanco
@id
Francisco J. Blanco
@nl
Francisco J. Blanco
@sl
P21
P27
P31
P496
0000-0003-2545-4319